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Eicosapentaenoic acid and docosahexaenoic acid are omega-3 polyunsaturated fatty 
acids with anti-inflammatory effects. They inhibit several pathways like toll like receptor 
activation, NALP-3 inflammasome assembly, neutrophil chemotaxis, prostaglandin 
synthesis and nucleating factor-kB activity through which monosodium urate (MSU) 
crystals induce inflammation (1-6). In keeping with these findings, mice fed on diet rich 
in omega-3 fatty acids developed less inflammation after subcutaneous injection of 
MSU crystals than those on standard diets (1, 7). Thus, omega-3 fatty acids have the 
potential of preventing acute attacks of gout. However, the association between 
omega-3 fatty acid levels and frequency of gout attacks has not been examined in 
humans. The objective of this study was to examine if omega-3 fatty acid levels 
associate with frequent gout attacks.  
This study was approved by the Nottinghamshire Research Ethics Committee-1. Data 
from 112 men with gout meeting the American College of Rheumatology classification 
criteria for gout and recruited from primary care were used (8). Patients were seen for 
one visit, had detailed metrologist assessments including height and weight 
measurement, self-reported their gout attack frequency in the previous 12 months, and 
had blood taken for measurement of omega-3 fatty acid and serum uric acid (SUA). 
For the present study, cases had >2 acute attacks while controls had ≤2 acute attacks 
of gout in the preceding 12 months. Odds ratio (OR) and 95% confidence intervals 
(95%CI) were calculated to examine the association between omega-3 fatty acid 
levels and gout attack frequency. This was adjusted for age, body mass index (kg/m2), 
disease duration and SUA (tertiles); and tophi, urate lowering treatment (absent or 
present) using binary logistic regression. Statistical analyses were carried out using 
Stata. Statistical significance was p<0.05. 
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The characteristics of the study participants are described in Table 1. The mean (SD) 
omega-3 fatty acid level was 0.41 (0.11) mmol/L. There was a non-significant trend for 
a negative association between omega-3 fatty acid levels and >2 acute attacks of gout 
in the previous 12 months (OR (95%CI) 0.68 (0.46-1.02) ptrend 0.06), however, it 
became significant after adjusting for covariates (aOR (95%CI) 0.62 (0.38 - 0.98), ptrend 
0.043) (Figure 1). 
This is the first report of an association between high omega-3 fatty acid levels and 
infrequent acute attacks of gout. This novel finding raises the possibility that 
supplementation with omega-3 fatty acids may be used to prevent acute attacks of 
gout. However, there are several caveats to the study. Firstly, the frequency of gout 
attack was self-reported retrospectively, and may be affected by biased recall. 
However, self-reported gout attack frequency is unlikely to be affected by the omega-
3 fatty acids levels, and will not result in a differential misclassification bias. 
Additionally, information about other factors that may affect gout attack frequency e.g. 
purine-rich alcohol consumption, red meat intake, and both gout attack frequency and 
omega-3 fatty acid levels e.g. sea-food intake were not available. Thus, the findings 
of this study should be confirmed in other studies in which information on lifestyle and 
dietary risk factors that affect gout attack frequency are collected. 
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Table 1 Disease and demographic characteristics of the study participants 
 Cases  
(n= 31) 
Controls  
(n=81) 
p  
value 
Age, mean (SD1) 59.67 (11.45) 64.44 (10.22) 0.03 
BMI, mean (SD) 29.54 (5.32) 29.86 (4.57) 0.76 
Disease duration, mean (SD) 9.53 (7.52) 12.93 (10.89) 0.11 
Tophi, n (%) present  4 (12.9%) 4 (5.0%) 0.14 
Serum uric acid, mean (SD) 424.52 (112.70) 391.77 (98.33) 0.13 
n (%) on urate lowering treatment 11 (35.5%) 36 (44.44%) 0.74 
Omega-3 fatty acid, range (mmol/L)    
≤0.355 9 18  
0.361 - 0.4025 10 16 
0.4067 – 0.4648 5 21  
≥ 0.4659 4 22 0.062 
1 SD (Standard Deviation); 2ptrend  
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Figure 1 Negative association between frequent gout attacks and increasing 
concentration of omega 3 fatty acid. The aOR for frequent gout attack reduces with 
increasing concentration of omega 3 fatty acid.
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